Literature DB >> 33197127

NHC-stabilized Parent Arsanylalanes and -gallanes.

Michael A K Weinhart1, Michael Seidl1, Alexey Y Timoshkin2, Manfred Scheer1.   

Abstract

The synthesis and characterization of the unprecedented compounds IDipp⋅E'H2 AsH2 (E'=Al, Ga; IDipp=1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene) are reported, the first monomeric, parent representatives of an arsanylalane and arsanylgallane, respectively, stabilized only by a LB (LB=Lewis Base). They are prepared by a salt metathesis reaction of KAsH2 with IDipp⋅E'H2 Cl (E'=Al, Ga). The H2 -elimination pathway through the reaction of AsH3 with IDipp⋅E'H3 (E'=Al, Ga) was found to be a possible synthetic route with some disadvantages compared to the salt metathesis reaction. The corresponding organo-substituted compounds IDippGaH2 AsPh2 (1) and IDippAlH2 AsPh2 (2) were obtained by the reaction of KAsPh2 with IDipp⋅E'H2 Cl (E'=Al, Ga). The novel branched parent compounds IDipp⋅E'H(EH2 )2 (E'=Al, Ga; E=P, As) were synthesized by salt metathesis reactions starting from IDipp⋅E'HCl2 (E'=Al, Ga). Supporting DFT computations give insight into the different synthetic pathways and the stability of the products.
© 2020 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Entities:  

Keywords:  Lewis bases; alanes; arsenic; gallanes; group 13/15 compounds

Year:  2020        PMID: 33197127     DOI: 10.1002/anie.202013849

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  An NHC-Stabilized H2 GeBH2 Precursor for the Preparation of Cationic Group 13/14/15 Hydride Chains.

Authors:  Matthias T Ackermann; Michael Seidl; Fuwei Wen; Michael J Ferguson; Alexey Y Timoshkin; Eric Rivard; Manfred Scheer
Journal:  Chemistry       Date:  2021-11-24       Impact factor: 5.020

Review 2.  Taming PH3: State of the Art and Future Directions in Synthesis.

Authors:  Thomas M Hood; Samantha Lau; Ruth L Webster
Journal:  J Am Chem Soc       Date:  2022-09-07       Impact factor: 16.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.